Literature DB >> 34792434

Isolation of 4000 SARS-CoV-2 shows that contagiousness is associated with viral load, not vaccine or symptomatic status.

Celine Boschi1,2, Sarah Aherfi1,2, Linda Houhamdi2, Philippe Colson1,2, Didier Raoult1,2, Bernard La Scola1,2.   

Abstract

Culture inoculation of 6722 nasopharyngeal samples since February 2020 allowed isolation of 3637 SARS-CoV-2 and confirmed that isolation rate is correlated to viral load, regardless symptomatology or vaccination status. Moreover, the delta variant is associated with higher viral loads and therefore higher rates of viral isolation, explaining its greater contagiousness.

Entities:  

Keywords:  SARS-CoV-2; culture; delta variant; symptomatology; vaccination

Mesh:

Substances:

Year:  2021        PMID: 34792434      PMCID: PMC8648030          DOI: 10.1080/22221751.2021.2008776

Source DB:  PubMed          Journal:  Emerg Microbes Infect        ISSN: 2222-1751            Impact factor:   7.163


Since February 2020 our BSL3 laboratory has been involved in massive SARS-CoV-2 isolation [1,2]. As a consequence, we early established a clear correlation between viral load and isolation of the virus in cell culture, which is an indirect marker of patient contagiousness. It was later suggested that asymptomatic SARS-CoV-2-infected patients or vaccinated infected patients would have a lower viral load and/or would be less contagious [3,4]. This prompted us to analyse the 6731 nasopharyngeal samples with a Ct < 35 at time of diagnosis inoculated in our BSL3 laboratory until July 2021 under previously described conditions [1,2]. Vaccinated patients were defined as those diagnosed ≥ 15 days after their first injection of any of the four vaccines available in Europe (https://ec.europa.eu/info/live-work-travel-eu/coronavirus-response/safe-covid-19-vaccines-europeans_fr). Then, we tested if the predominant SARS-CoV-2 variant at time of diagnosis was associated with a different Ct and culture positivity rate. We studied four periods: (i) February–September 2020 (Wuhan-Hu-1 close virus derivatives (French original viruses)), (ii) October–December 2020 (predominance of 20A.EU2 variant, in 1684/2135 (79%) of the samples with viral genotype available); (iii) January–June 2020 (predominance of alpha variant; 9060/14,495 (63%) samples with viral genotype available); and (iv) July 2021 (delta variant, 1932/2031 (95%) samples with viral genotype available). Statistical analysis was performed on GraphPad prism 5.03 using One-way Anova or Mann–Whitney tests. We could isolate 3637 (54%) SARS-CoV-2 from the 6722 patients’s samples inoculated (mean age ± standard deviation: 60.5 years old ± 21 years old). Culture positivity was inversely proportional to Ct at diagnosis as Ct was significantly lower for patients with a positive than negative culture (mean ± standard deviation: 23.2 ± 4.83 versus 28.3 ± 4.9, respectively; p < 0.0001) (Figure 1(a)). Symptomatic or asymptomatic status was known for 3761 and 543 patients, respectively. Mean Ct was significantly lower in asymptomatic than symptomatic patients (23.1 ± 5.9 versus 26.1 ± 5.4, respectively; p < 0.0001) (Figure 1(a)). Regarding culture isolation, it was positive for 50% (1882/3761) of symptomatic patients compared to 69% (372/543) of asymptomatic patients (p < 0.0001) (Figure 1(b)). Since January 2021, we inoculated 309 samples from vaccinated patients and 433 samples from unvaccinated. Ct at diagnosis was significantly lower for vaccinated patients than unvaccinated patients (21.5 ± 4.5 versus 23.4 ± 5.4, respectively) (Figure 1(a)) (p < 0.0001). We isolated 80% (249/309) of SARS-CoV-2 among vaccinated patients versus 66% (287/433) among unvaccinated patients (p < 0.0001) (Figure 1(b)). For the 150 vaccinated patients for whom this information was available, 134 (89%) were symptomatic and 16 (11%) were asymptomatic (Figure 1(c)). We were able to isolate 74% and 63% of strains among the vaccinated patients symptomatic and asymptomatic, respectively (NS). For the 209 unvaccinated patients for whom this information was available, 167 (80%) were symptomatic and 42 (20%) were asymptomatic. The proportion of symptomatic patients was statistically different from that among vaccinated patients (p = 0.008) (Figure 1(c)). We were able to isolate 65% and 72% of strains among the unvaccinated patients symptomatic and asymptomatic, respectively (NS). Finally, there was no significant difference between mean Ct of the periods with the French original SARS-CoV-2 and during which the 20A.EU2 variant predominated (25.6 ± 5.5 versus 25.7 ± 5.5 respectively). In contrast, mean Ct was significantly lower for periods during which the alpha (22.6 ± 5.2) then delta variants (19.7 ± 3.4) predominated than for the two former periods, and between January and June than in July (p < 0.0001) (Figure 1(d)). In addition, the culture isolation rate was inversely correlated with the Ct (Figure 1(e)) (p < 0.0001).
Figure 1.

(a) Correlation between viral load evaluated by RT-PCR Ct and positive culture among symptomatics and asymptomatics patients, (b) percentage of negative and positive culture among symptomatic/asymptomatic and vaccinated/unvaccinated, (c) percentage of symptomatic patients among vaccinated and unvaccinated, (d) correlation between viral load evaluated by RT-PCR Ct and time of sampling, and (e) percentage of positive and negative cultures during time of sampling.

(a) Correlation between viral load evaluated by RT-PCR Ct and positive culture among symptomatics and asymptomatics patients, (b) percentage of negative and positive culture among symptomatic/asymptomatic and vaccinated/unvaccinated, (c) percentage of symptomatic patients among vaccinated and unvaccinated, (d) correlation between viral load evaluated by RT-PCR Ct and time of sampling, and (e) percentage of positive and negative cultures during time of sampling. We herein confirm relationship between qPCR Ct at diagnosis and SARS-CoV-2 isolation despite culture viral isolation sensitivity could vary dramatically according to the procedure [1,2,5,6]. Such correlation was independent of the period of study, of the presence or absence of clinical symptoms, and of the vaccination status of the patients. Patients symptomatic at SARS-CoV-2 diagnosis had lower culture isolation rate than asymptomatic patients, regardless they were vaccinated or not (Figures 1(a–c)), probably because these later may test earlier in the course of infection, when viral loads are highest. Vaccinated patients have also higher culture isolation rates than unvaccinated (Figures 1(a,b)). A bias in the selection of patients coming to our institute to be tested for SARS-CoV-2 infection is possible, but such correlation has already been observed among healthcare workers immediately after vaccination for whom the absolute risk of testing SARS-CoV-2-positive was increased without obvious explanation [7]. As previously observed in London between November and December 2020, viral loads during the period for which the alpha variant largely predominated were higher than with previous variants [8]. The same picture is observed now with delta variant as compared to alpha variant in China [9] and US [10], regardless of their vaccination status. The lack of information about the proportion of fully vaccinated patients (2-dose course of vaccine ≥ 14 days before SARS-CoV-2 infection) could be considered a weakness in our work. After one dose of vaccine, specific antibodies against SARS-CoV-2 are produced within 2 weeks of injection, although rates of protection may vary from one patient to another so this is an important issue to consider [11]. However, Ct was also similar among samples from patients fully vaccinated or not in the study by Brown et al. [12] who enrolled 74% of patients fully vaccinated and 90% infected with the delta variant. The present work confirms that higher viral loads observed with the delta variant are correlated to a higher positivity rate of culture virus isolation, and therefore to higher contagiousness of patients, regardless of the vaccination status of the patients and/or the presence or absence of clinical symptoms.
  10 in total

1.  Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine.

Authors:  Matan Levine-Tiefenbrun; Idan Yelin; Rachel Katz; Esma Herzel; Ziv Golan; Licita Schreiber; Tamar Wolf; Varda Nadler; Amir Ben-Tov; Jacob Kuint; Sivan Gazit; Tal Patalon; Gabriel Chodick; Roy Kishony
Journal:  Nat Med       Date:  2021-03-29       Impact factor: 53.440

2.  Correlation Between 3790 Quantitative Polymerase Chain Reaction-Positives Samples and Positive Cell Cultures, Including 1941 Severe Acute Respiratory Syndrome Coronavirus 2 Isolates.

Authors:  Rita Jaafar; Sarah Aherfi; Nathalie Wurtz; Clio Grimaldier; Thuan Van Hoang; Philippe Colson; Didier Raoult; Bernard La Scola
Journal:  Clin Infect Dis       Date:  2021-06-01       Impact factor: 9.079

3.  Virological assessment of hospitalized patients with COVID-2019.

Authors:  Roman Wölfel; Victor M Corman; Wolfgang Guggemos; Michael Seilmaier; Sabine Zange; Marcel A Müller; Daniela Niemeyer; Terry C Jones; Patrick Vollmar; Camilla Rothe; Michael Hoelscher; Tobias Bleicker; Sebastian Brünink; Julia Schneider; Rosina Ehmann; Katrin Zwirglmaier; Christian Drosten; Clemens Wendtner
Journal:  Nature       Date:  2020-04-01       Impact factor: 49.962

4.  Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards.

Authors:  Bernard La Scola; Marion Le Bideau; Julien Andreani; Van Thuan Hoang; Clio Grimaldier; Philippe Colson; Philippe Gautret; Didier Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-04-27       Impact factor: 3.267

5.  Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study.

Authors:  Dan Frampton; Tommy Rampling; Aidan Cross; Heather Bailey; Judith Heaney; Matthew Byott; Rebecca Scott; Rebecca Sconza; Joseph Price; Marios Margaritis; Malin Bergstrom; Moira J Spyer; Patricia B Miralhes; Paul Grant; Stuart Kirk; Chris Valerio; Zaheer Mangera; Thaventhran Prabhahar; Jeronimo Moreno-Cuesta; Nish Arulkumaran; Mervyn Singer; Gee Yen Shin; Emilie Sanchez; Stavroula M Paraskevopoulou; Deenan Pillay; Rachel A McKendry; Mariyam Mirfenderesky; Catherine F Houlihan; Eleni Nastouli
Journal:  Lancet Infect Dis       Date:  2021-04-12       Impact factor: 25.071

6.  SARS-CoV-2 Infection after Vaccination in Health Care Workers in California.

Authors:  Jocelyn Keehner; Lucy E Horton; Michael A Pfeffer; Christopher A Longhurst; Robert T Schooley; Judith S Currier; Shira R Abeles; Francesca J Torriani
Journal:  N Engl J Med       Date:  2021-03-23       Impact factor: 91.245

7.  Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission.

Authors:  Lucy Rivett; Sushmita Sridhar; Dominic Sparkes; Matthew Routledge; Nick K Jones; Ian G Goodfellow; Stephen Baker; Michael P Weekes; Sally Forrest; Jamie Young; Joana Pereira-Dias; William L Hamilton; Mark Ferris; M Estee Torok; Luke Meredith; Martin D Curran; Stewart Fuller; Afzal Chaudhry; Ashley Shaw; Richard J Samworth; John R Bradley; Gordon Dougan; Kenneth Gc Smith; Paul J Lehner; Nicholas J Matheson; Giles Wright
Journal:  Elife       Date:  2020-05-11       Impact factor: 8.140

8.  Culture-Based Virus Isolation To Evaluate Potential Infectivity of Clinical Specimens Tested for COVID-19.

Authors:  Chung-Guei Huang; Kuo-Ming Lee; Mei-Jen Hsiao; Shu-Li Yang; Peng-Nien Huang; Yu-Nong Gong; Tzu-Hsuan Hsieh; Po-Wei Huang; Ya-Jhu Lin; Yi-Chun Liu; Kuo-Chien Tsao; Shin-Ru Shih
Journal:  J Clin Microbiol       Date:  2020-07-23       Impact factor: 5.948

9.  Differential Antibody Response to mRNA COVID-19 Vaccines in Healthy Subjects.

Authors:  Sarah E Wheeler; Galina V Shurin; Mary Yost; Adam Anderson; Lisa Pinto; Alan Wells; Michael R Shurin
Journal:  Microbiol Spectr       Date:  2021-08-04

10.  Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings - Barnstable County, Massachusetts, July 2021.

Authors:  Catherine M Brown; Johanna Vostok; Hillary Johnson; Meagan Burns; Radhika Gharpure; Samira Sami; Rebecca T Sabo; Noemi Hall; Anne Foreman; Petra L Schubert; Glen R Gallagher; Timelia Fink; Lawrence C Madoff; Stacey B Gabriel; Bronwyn MacInnis; Daniel J Park; Katherine J Siddle; Vaira Harik; Deirdre Arvidson; Taylor Brock-Fisher; Molly Dunn; Amanda Kearns; A Scott Laney
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-08-06       Impact factor: 17.586

  10 in total
  3 in total

1.  Seroprevalence of SARS-CoV-2 among high-density communities and hyper-endemicity of COVID-19 in Vietnam.

Authors:  Van Thuan Hoang; Thi Dung Pham; Quoc Tien Nguyen; Duy Cuong Nguyen; Duc Thanh Nguyen; Thanh Binh Nguyen; Thi Khanh Thu Tran; Trong Lan Phan; Phan Le Nguyen Vo; Thi Loi Dao; Florence Fenollar; Philippe Gautret
Journal:  Trop Med Int Health       Date:  2022-03-25       Impact factor: 3.918

2.  The Usefulness of Antigen Testing in Predicting Contagiousness in COVID-19.

Authors:  Tulio J Lopera; Juan Carlos Alzate-Ángel; Francisco J Díaz; María T Rugeles; Wbeimar Aguilar-Jiménez
Journal:  Microbiol Spectr       Date:  2022-03-29

3.  SARS-CoV-2 Vaccination and Protection Against Clinical Disease: A Retrospective Study, Bouches-du-Rhône District, Southern France, 2021.

Authors:  Pierre-Edouard Fournier; Linda Houhamdi; Philippe Colson; Sébastien Cortaredona; Lea Delorme; Carole Cassagne; Jean-Christophe Lagier; Hervé Chaudet; Hervé Tissot-Dupont; Audrey Giraud-Gatineau; Florence Fenollar; Matthieu Million; Didier Raoult
Journal:  Front Microbiol       Date:  2022-01-18       Impact factor: 5.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.